G-protein-coupled receptors: new approaches to maximise the impact of GPCRS in drug discovery
- PMID: 15102557
- DOI: 10.1517/14728222.8.2.165
G-protein-coupled receptors: new approaches to maximise the impact of GPCRS in drug discovery
Abstract
IBC's Drug Discovery Technology Series is a group of conferences highlighting technological advances and applications in niche areas of the drug discovery pipeline. This 2-day meeting focused on G-protein-coupled receptors (GPCRs), probably the most important and certainly the most valuable class of targets for drug discovery. The meeting was chaired by J Beesley (Vice President, European Business Development for LifeSpan Biosciences, Seattle, USA) and included 17 presentations on various aspects of GPCR activity, drug screens and therapeutic analyses. Keynote Addresses covered two of the emerging areas in GPCR regulation; receptor dimerisation (G Milligan, Professor of Molecular Pharmacology and Biochemistry, University of Glasgow, UK) and proteins that interact with GPCRs (J Bockaert, Laboratory of Functional Genomics, CNRS Montpellier, France). A third Keynote Address from W Thomsen (Director of GPCR Drug Screening, Arena Pharmaceuticals, USA) discussed Arena's general approach to drug discovery and illustrated this with reference to the development of an agonist with potential efficacy in Type II diabetes.
Similar articles
-
GPCR-GIP networks: a first step in the discovery of new therapeutic drugs?Curr Opin Drug Discov Devel. 2004 Sep;7(5):649-57. Curr Opin Drug Discov Devel. 2004. PMID: 15503867 Review.
-
G protein-coupled receptors in drug discovery.Assay Drug Dev Technol. 2003 Apr;1(2):305-10. doi: 10.1089/15406580360545116. Assay Drug Dev Technol. 2003. PMID: 15090195 Review.
-
Modeling the 3D structure of GPCRs: advances and application to drug discovery.Curr Opin Drug Discov Devel. 2003 May;6(3):353-61. Curr Opin Drug Discov Devel. 2003. PMID: 12833668 Review.
-
Constitutively activated G protein-coupled receptors: a novel approach to CNS drug discovery.Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):105-21. doi: 10.2174/1568007023339508. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769637 Review.
-
The use of constitutively active GPCRs in drug discovery and functional genomics.Nat Rev Drug Discov. 2002 Aug;1(8):599-608. doi: 10.1038/nrd872. Nat Rev Drug Discov. 2002. PMID: 12402500 Review.
Cited by
-
Promoting crystallization of intrinsic membrane proteins with conjugated micelles.Sci Rep. 2020 Jul 22;10(1):12199. doi: 10.1038/s41598-020-68689-6. Sci Rep. 2020. PMID: 32699228 Free PMC article.
-
Membrane protein structure determination - the next generation.Biochim Biophys Acta. 2014 Jan;1838(1 Pt A):78-87. doi: 10.1016/j.bbamem.2013.07.010. Epub 2013 Jul 13. Biochim Biophys Acta. 2014. PMID: 23860256 Free PMC article. Review.
-
Enhanced Electrophoretic Depletion of Sodium Dodecyl Sulfate with Methanol for Membrane Proteome Analysis by Mass Spectrometry.Proteomes. 2024 Feb 2;12(1):5. doi: 10.3390/proteomes12010005. Proteomes. 2024. PMID: 38390965 Free PMC article.
-
Probing Membrane Protein Association Using Concentration-Dependent Number and Brightness.Angew Chem Int Ed Engl. 2021 Mar 15;60(12):6503-6508. doi: 10.1002/anie.202010049. Epub 2021 Feb 4. Angew Chem Int Ed Engl. 2021. PMID: 33351993 Free PMC article.
-
Interactions between AT1R and GRKs: the determinants for activation of signaling pathways involved in blood pressure regulation.Mol Biol Rep. 2023 Dec 29;51(1):46. doi: 10.1007/s11033-023-08995-0. Mol Biol Rep. 2023. PMID: 38158508 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
